Breast Cancer Clinical Trials in Chicago

Showing 601-611 of 611 trials

A Randomized, Placebo-Controlled Trial of BMS-275291 Given Daily for 12 Months to Women With Stage 1c-IIIA Breast Cancer Receiving Adjuvant Chemotherapy and/or Hormonal Therapy

NCT00036621

This clinical trial will assess whether BMS-275291 can be administered safely in combination with standard adjuvant therapy for early breast cancer and whether plasma concentrations at trough exceed a target minimum.

Breast Cancer

Bristol-Myers Squibb

Chicago, Illinois, United States • Indianapolis, Indiana, United States • Baltimore, Maryland, United States +6 more locations

COMPLETEDPhase 32.2 miles

Chemotherapy in Treating Women With Breast Cancer That Can Be Surgically Removed

NCT00002707

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. It is not yet known if chemotherapy given before surgery is more effective with or without docetaxel given before or after surgery for breast cancer. PURPOSE: Randomized phase III trial to compare the effectiveness of chemotherapy using doxorubicin and cyclophosphamide with or without docetaxel in treating women who have stage II or stage III breast cancer.

Breast Cancer

NSABP Foundation Inc2,411 participantsStarted Dec 1995

Huntsville, Alabama, United States • Phoenix, Arizona, United States • Greenbrae, California, United States +142 more locations

A Randomized, Placebo-Controlled Trial of BMS-275291 Given Daily for 12 Months to Women With Stage 1c-IIIA Breast Cancer Receiving Adjuvant Chemotherapy and/or Hormonal Therapy

Chemotherapy in Treating Women With Breast Cancer That Can Be Surgically Removed

Breast Cancer Trials in Other Cities

Breast Cancer Trial of RPR109881 Versus Capecitabine in Male or Female Patients With Advanced Breast Cancer

A Study of Women With an Early Diagnosis of Breast Cancer, Taking Celecoxib Between the Biopsy and Lumpectomy/Mastectomy

A Phase III Trial For Patients With Metastatic Breast Cancer

Photodynamic Therapy System for Patients With Refractory/Unresponsive Solid Tumors

Fulvestrant (FASLODEX™) as a Treatment in Postmenopausal Women With Estrogen Receptor Positive Breast Cancer

Paclitaxel With or Without PSC 833 in Treating Patients With Metastatic Breast Cancer

A Study Comparing Oral Picoplatin With Intravenous Picoplatin in Subjects With Solid Tumors

Pemetrexed Plus Gemcitabine in Metastatic Breast Cancer Patients After Receiving Taxane Therapy

Study of Alimta and Epirubicin Administered in Patients With Locally Advanced or Metastatic Breast Cancer

Other Conditions in Chicago